Cargando…

The Clinical Value of Flow Cytometric DNA Content Analysis in Patients with Soft Tissue Sarcomas

Purpose. The purpose of this study was to evaluate: (1) the correlation between grade and ploidy or S-phase fraction (SPF), (2) the prognostic value of DNA flow cytometric study in soft tissue sarcomas. Patients /Methods. In all, 47 tissue samples from soft tissue sarcoma patients, surgically treate...

Descripción completa

Detalles Bibliográficos
Autores principales: Samur, Mustafa, Pamir, Ali, Akbulut, Hakan, Erekul, Selim, Sağlik, Yener, Yildiz, Yusuf, Dinçol, Dilek, Içli, Fikri
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 1999
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395432/
https://www.ncbi.nlm.nih.gov/pubmed/18521281
http://dx.doi.org/10.1080/13577149977604
_version_ 1782155505090691072
author Samur, Mustafa
Pamir, Ali
Akbulut, Hakan
Erekul, Selim
Sağlik, Yener
Yildiz, Yusuf
Dinçol, Dilek
Içli, Fikri
author_facet Samur, Mustafa
Pamir, Ali
Akbulut, Hakan
Erekul, Selim
Sağlik, Yener
Yildiz, Yusuf
Dinçol, Dilek
Içli, Fikri
author_sort Samur, Mustafa
collection PubMed
description Purpose. The purpose of this study was to evaluate: (1) the correlation between grade and ploidy or S-phase fraction (SPF), (2) the prognostic value of DNA flow cytometric study in soft tissue sarcomas. Patients /Methods. In all, 47 tissue samples from soft tissue sarcoma patients, surgically treated in the same center, were included. Flow cytometric analyses were performed according to a modified version of the original method of Hedley et al. Results. DNA ploidy status could be determined in 44 samples out of 47 (success rate 94%). Of these 44, S-phase fraction could be calculated in 34 samples (77%). In the study group as a whole, aneuploidy was significantly correlated with high grade. Survival analyses were carried out in 21 patients with soft tissue sarcoma, all surgically treated in the same center, without chemotherapy or radiotherapy. In univariate analyses, DNA ploidy was found to be a significant factor for overall survival (OAS) and metastasis-free survival MFS. Mean OAS for aneuploid tumors and diploid tumors were 35 and 65 months (p=0.034), and mean MFS 23 and 61 months, respectively (p=0.005) . Discussion.There is a relation between histological grade and ploidy in soft tissue sarcomas. It appears that low-grade tumors are generally diploid, whereas high-grade tumors tend to be aneuploid. In a subgroup of patients treated only with surgery, DNA ploidy was found to be an important factor for predicting OAS and MFS.
format Text
id pubmed-2395432
institution National Center for Biotechnology Information
language English
publishDate 1999
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-23954322008-06-02 The Clinical Value of Flow Cytometric DNA Content Analysis in Patients with Soft Tissue Sarcomas Samur, Mustafa Pamir, Ali Akbulut, Hakan Erekul, Selim Sağlik, Yener Yildiz, Yusuf Dinçol, Dilek Içli, Fikri Sarcoma Research Article Purpose. The purpose of this study was to evaluate: (1) the correlation between grade and ploidy or S-phase fraction (SPF), (2) the prognostic value of DNA flow cytometric study in soft tissue sarcomas. Patients /Methods. In all, 47 tissue samples from soft tissue sarcoma patients, surgically treated in the same center, were included. Flow cytometric analyses were performed according to a modified version of the original method of Hedley et al. Results. DNA ploidy status could be determined in 44 samples out of 47 (success rate 94%). Of these 44, S-phase fraction could be calculated in 34 samples (77%). In the study group as a whole, aneuploidy was significantly correlated with high grade. Survival analyses were carried out in 21 patients with soft tissue sarcoma, all surgically treated in the same center, without chemotherapy or radiotherapy. In univariate analyses, DNA ploidy was found to be a significant factor for overall survival (OAS) and metastasis-free survival MFS. Mean OAS for aneuploid tumors and diploid tumors were 35 and 65 months (p=0.034), and mean MFS 23 and 61 months, respectively (p=0.005) . Discussion.There is a relation between histological grade and ploidy in soft tissue sarcomas. It appears that low-grade tumors are generally diploid, whereas high-grade tumors tend to be aneuploid. In a subgroup of patients treated only with surgery, DNA ploidy was found to be an important factor for predicting OAS and MFS. Hindawi Publishing Corporation 1999-12 /pmc/articles/PMC2395432/ /pubmed/18521281 http://dx.doi.org/10.1080/13577149977604 Text en Copyright © 1999 Hindawi Publishing Corporation. http://creativecommons.org/licenses/by/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Samur, Mustafa
Pamir, Ali
Akbulut, Hakan
Erekul, Selim
Sağlik, Yener
Yildiz, Yusuf
Dinçol, Dilek
Içli, Fikri
The Clinical Value of Flow Cytometric DNA Content Analysis in Patients with Soft Tissue Sarcomas
title The Clinical Value of Flow Cytometric DNA Content Analysis in Patients with Soft Tissue Sarcomas
title_full The Clinical Value of Flow Cytometric DNA Content Analysis in Patients with Soft Tissue Sarcomas
title_fullStr The Clinical Value of Flow Cytometric DNA Content Analysis in Patients with Soft Tissue Sarcomas
title_full_unstemmed The Clinical Value of Flow Cytometric DNA Content Analysis in Patients with Soft Tissue Sarcomas
title_short The Clinical Value of Flow Cytometric DNA Content Analysis in Patients with Soft Tissue Sarcomas
title_sort clinical value of flow cytometric dna content analysis in patients with soft tissue sarcomas
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395432/
https://www.ncbi.nlm.nih.gov/pubmed/18521281
http://dx.doi.org/10.1080/13577149977604
work_keys_str_mv AT samurmustafa theclinicalvalueofflowcytometricdnacontentanalysisinpatientswithsofttissuesarcomas
AT pamirali theclinicalvalueofflowcytometricdnacontentanalysisinpatientswithsofttissuesarcomas
AT akbuluthakan theclinicalvalueofflowcytometricdnacontentanalysisinpatientswithsofttissuesarcomas
AT erekulselim theclinicalvalueofflowcytometricdnacontentanalysisinpatientswithsofttissuesarcomas
AT saglikyener theclinicalvalueofflowcytometricdnacontentanalysisinpatientswithsofttissuesarcomas
AT yildizyusuf theclinicalvalueofflowcytometricdnacontentanalysisinpatientswithsofttissuesarcomas
AT dincoldilek theclinicalvalueofflowcytometricdnacontentanalysisinpatientswithsofttissuesarcomas
AT iclifikri theclinicalvalueofflowcytometricdnacontentanalysisinpatientswithsofttissuesarcomas
AT samurmustafa clinicalvalueofflowcytometricdnacontentanalysisinpatientswithsofttissuesarcomas
AT pamirali clinicalvalueofflowcytometricdnacontentanalysisinpatientswithsofttissuesarcomas
AT akbuluthakan clinicalvalueofflowcytometricdnacontentanalysisinpatientswithsofttissuesarcomas
AT erekulselim clinicalvalueofflowcytometricdnacontentanalysisinpatientswithsofttissuesarcomas
AT saglikyener clinicalvalueofflowcytometricdnacontentanalysisinpatientswithsofttissuesarcomas
AT yildizyusuf clinicalvalueofflowcytometricdnacontentanalysisinpatientswithsofttissuesarcomas
AT dincoldilek clinicalvalueofflowcytometricdnacontentanalysisinpatientswithsofttissuesarcomas
AT iclifikri clinicalvalueofflowcytometricdnacontentanalysisinpatientswithsofttissuesarcomas